Combination therapy using the programmed death receptor-1 and the programmed death-ligand 1 inhibitors and Fluorouracil in human colorectal carcinoma in a humanized patient-derived orthotopic mouse model.

Combination therapy using the programmed death receptor-1 and the programmed death-ligand 1 inhibitors and Fluorouracil in human colorectal carcinoma in a humanized patient-derived orthotopic mouse model. Article

Web of Science: 000518188200225

Cited authors

Zhang, Xin; Maresh, Grace; Hellmers, Linh; Yip, Henry; Baste, Lara McKean; Green, Heather; Margolin, David; Li, Li

Authors

Margolin, David, MD, FACS, FASCRS

Publication date

2020

Published in

Cancer Immunology Research Journal

Category

IMMUNOLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

2326-6066

Start page

128

End page

128

Volume

8

Issue

3